Stop CMV Act of 2025
Sponsored By: Representative Lawler, Michael [R-NY-17]
Introduced
Summary
Nationwide newborn screening for congenital CMV. This bill would create a federal framework to offer CMV testing to infants and to support state standards, funding, provider education, and research.
Show full summary
- Families and newborns: Hospitals and other health care entities caring for infants 21 days old or younger may administer a CMV test to every infant in their care, with requirements for recording results, tracking, and follow-up reviews.
- States and providers: State chief health officers could set standards and information rules. If a State fails to adopt approved standards within two years, the Advisory Committee on Heritable Disorders in Newborns and Children would prescribe standards. The Health Resources and Services Administration would award grants to States to support testing operations.
- Public health and research: The Centers for Disease Control and Prevention would fund technical assistance, data systems, and education. The National Institutes of Health would expand or create research programs on screening methods, interventions, diagnostics, prevention, and vaccine development. The Advisory Committee would gain explicit authority to review and approve CMV screening activities.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
Newborn CMV tests offered in hospitals
If enacted, hospitals and similar providers could test every infant 21 days old or younger for congenital CMV. States that adopt approved testing rules could get HRSA funds and pass money to hospitals to run the tests. The bill authorizes “such sums as necessary” for fiscal years 2025 and 2026. This could make CMV screening at birth more available in many hospitals.
CDC grants for CMV data and education
CDC could give grants or cooperative agreements to States. Money would help build CMV data systems and train providers, patients, and the public. Funds could support evidence-based materials on State websites. The bill authorizes “such sums as necessary” for 2025 and 2026.
NIH research on CMV tests and care
NIH would start or expand research on better CMV screening methods and interventions. It would also support work on diagnostics, prevention, public awareness, treatments during pregnancy and after birth, and vaccine development. These are research programs and would not send direct payments to families.
State CMV screening rules with federal backup
States would set standards for how newborn CMV testing is done, how results are tracked, and how parents are informed. A federal advisory committee would review and approve each State’s standards. If a State has no approved standards within 2 years after enactment, the committee would set standards for that State. The committee would consider other States’ rules, that State’s other newborn screening rules, and scientific evidence.
Sponsors & CoSponsors
Sponsor
Lawler, Michael [R-NY-17]
NY • R
Cosponsors
Rep. Landsman, Greg [D-OH-1]
OH • D
Sponsored 9/17/2025
Rep. Ross, Deborah K. [D-NC-2]
NC • D
Sponsored 9/17/2025
Rep. Vindman, Eugene Simon [D-VA-7]
VA • D
Sponsored 10/8/2025
Rep. Gottheimer, Josh [D-NJ-5]
NJ • D
Sponsored 10/17/2025
Rep. Pappas, Chris [D-NH-1]
NH • D
Sponsored 11/17/2025
Rep. Sorensen, Eric [D-IL-17]
IL • D
Sponsored 11/17/2025
Rep. Alford, Mark [R-MO-4]
MO • R
Sponsored 11/19/2025
Rep. Gillen, Laura [D-NY-4]
NY • D
Sponsored 12/15/2025
Schrier
WA • D
Sponsored 1/7/2026
Rep. Ansari, Yassamin [D-AZ-3]
AZ • D
Sponsored 3/17/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov